The Effect of Stress Ball Use on Stress, Anxiety, and Vital Signs in Patients Undergoing Chemotherapy for Breast Cancer
Launched by ATATURK UNIVERSITY · Jul 16, 2025
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether using a stress ball can help reduce feelings of stress and anxiety, and improve vital signs like heart rate and blood pressure, in patients receiving chemotherapy for early-stage breast cancer. The study will involve 50 patients who are undergoing chemotherapy treatments every three weeks and are at certain stages of breast cancer (specifically stage 2A or 2B). The goal is to see if squeezing a stress ball during chemotherapy sessions can make the experience more comfortable and less stressful.
To join this study, patients need to be adults diagnosed with breast cancer at the specified stages and currently receiving their second or later chemotherapy treatment. They should not have certain health issues like migraines, seizures, or brain cancer, and must be able to use their hands to squeeze the stress ball. During the study, participants will be randomly assigned to either use a stress ball or not during their chemotherapy. Researchers will measure stress and anxiety levels before and after treatment to see if the stress ball makes a difference. This study is important because it explores a simple, drug-free way to help patients feel better during chemotherapy, which could improve their overall treatment experience.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Stage 2A-2B breast cancer
- • Receiving neoadjuvant chemotherapy
- • On a chemotherapy protocol administered every 21 days
- • Receiving second or subsequent chemotherapy cycle
- • No migraine, vertigo, active nausea, vomiting, or headache
- • No history of seizures
- • No primary or metastatic brain cancer
- • No visual, hearing, or cognitive impairment
- • Age 18 or older
- • No communication barriers
- • Voluntary participation
- Exclusion Criteria:
- • Cancer types other than breast cancer
- • Unilateral or bilateral mastectomy
- • Any condition preventing hand use (e.g., pain, fracture, open wound)
- • IV access in both arms
- • Psychiatric diagnosis
- • Diagnosed anxiety disorder or current anti-anxiety medication use
About Ataturk University
Atatürk University, located in Erzurum, Turkey, is a prominent academic institution dedicated to advancing research and education across various disciplines. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate innovative medical research aimed at improving patient outcomes and contributing to the global body of health knowledge. Committed to ethical standards and rigorous scientific methodologies, Atatürk University collaborates with healthcare professionals, researchers, and regulatory bodies to ensure the integrity and efficacy of its clinical trials, ultimately enhancing the quality of care and driving advancements in medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported